Transplantation, AutologousMultiple MyelomaHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousMelphalanPeripheral Blood Stem Cell TransplantationTransplantation ConditioningCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeBone Marrow TransplantationRemission InductionSalvage TherapyStem CellsHematopoietic Stem Cell MobilizationDisease-Free SurvivalLymphoma, Non-HodgkinRecurrenceHodgkin DiseaseCyclophosphamideEtoposideCarmustineMyeloablative AgonistsLiver TransplantationGraft vs Host DiseaseBone Marrow PurgingCytarabineBoronic AcidsSurvival RateThalidomidePyrazinesVincristineHematologic NeoplasmsGraft SurvivalWhole-Body IrradiationSurvival AnalysisRetrospective StudiesHematopoietic Stem CellsDexamethasoneBusulfanThiotepaAntigens, CD34Kidney TransplantationAmyloidosisPrognosisLymphoma, Mantle-CellLeukapheresisFollow-Up StudiesGranulocyte Colony-Stimulating FactorAntineoplastic Agents, AlkylatingDoxorubicinCell TransplantationAntibodies, Monoclonal, Murine-DerivedPrednisoneTime FactorsAutograftsLymphomaTransplantation ChimeraLymphoma, FollicularMesenchymal Stem Cell TransplantationTissue DonorsLymphoma, T-Cell, PeripheralAntineoplastic AgentsNeoplasm, ResidualLeukemia, Plasma CellHeart TransplantationCord Blood Stem Cell TransplantationBone MarrowImmunosuppressive AgentsLeukemia, Myeloid, AcuteMaintenance ChemotherapyPodophyllotoxinIfosfamideInduction ChemotherapyLung TransplantationBlood Component RemovalMyeloma ProteinsMyelodysplastic SyndromesIdarubicinLymphoma, Large B-Cell, DiffuseAntibodies, MonoclonalFeasibility StudiesHistocompatibility TestingBone Marrow CellsProspective StudiesLymphoma, B-CellTransplantation ImmunologyOrgan TransplantationBlood Transfusion, AutologousEmbryonic Stem CellsGraft RejectionLeukemiaCell DifferentiationHematopoiesisGraft vs Tumor EffectEnteropathy-Associated T-Cell LymphomaNeoplasms, Second PrimaryImmunoglobulin Light ChainsInfusions, Spinal